Therapeutic advances in neurological disorders

Keyphrases

Publications

volume 17, 2024

Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Kathryn C Fitzgerald, Rodden M Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Salter Amber
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic advances in neurological disorders 17 (2024)
Weiyi Zhong, Yiwei Xia, Yunqing Ying, Yi Wang, Lumeng Yang, Xiaoniu Liang, Qianhua Zhao, Jianjun Wu, Zonghui Liang, Xiaoxiao Wang, Xin Cheng, Ding Ding, Qiang Dong
Cerebral pulsatility in relation with various imaging markers of cerebral small vessel disease: a longitudinal community-based study. Therapeutic advances in neurological disorders 17 (2024)
Weiyi Zhong, Yiwei Xia, Yunqing Ying, Yi Wang, Lumeng Yang, Xiaoniu Liang, Qianhua Zhao, Jianjun Wu, Zonghui Liang, Xiaoxiao Wang, Xin Cheng, Ding Ding, Qiang Dong
Cerebral pulsatility in relation with various imaging markers of cerebral small vessel disease: a longitudinal community-based study. Therapeutic advances in neurological disorders 17 (2024)
Suhui Kuang, Shaohui Zhang, Zhiqiang Cui, Ming Ge, Liu Yuan, Jiaqi Wang, Zhirong Wei, Jinshan Xu, Feng Zhai, Shuli Liang
Clinical characteristics and surgical outcomes of low-grade epilepsy-associated brain tumors. Therapeutic advances in neurological disorders 17 (2024)
Fang Fang, Xiao-Xi Lan, Rong-Hua Hu, Wu-Han Hui, Hong Zhao, Yi-Xian Guo, Bing-Xin Ji, Hong-Jun Liu, Li Su, Wan-Ling Sun
Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients. Therapeutic advances in neurological disorders 17 (2024)
Nicholas Riley, Susan Lavinia Greco, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van Der Walt, Erin O Y Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A Samjoo
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons. Therapeutic advances in neurological disorders 17 (2024)
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van Der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman, null null
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic advances in neurological disorders 17 (2024)
Tobias Brummer, Johannes Lotz, Christian Dresel, Frank Birklein
Anti-NMDA-receptor encephalitis and concurrent neuroborreliosis misdiagnosed for post-COVID-19-syndrome: a case report. Therapeutic advances in neurological disorders 17 (2024)
Chaofeng Zhu, Juan Li, Dazhu Wei, Luyan Wu, Yuying Zhang, Huapin Huang, Wanhui Lin
Intrinsic brain activity differences in perampanel-responsive and non-responsive drug-resistant epilepsy patients: an EEG microstate analysis. Therapeutic advances in neurological disorders 17 (2024)
Chaofeng Zhu, Juan Li, Dazhu Wei, Luyan Wu, Yuying Zhang, Huapin Huang, Wanhui Lin
Intrinsic brain activity differences in perampanel-responsive and non-responsive drug-resistant epilepsy patients: an EEG microstate analysis. Therapeutic advances in neurological disorders 17 (2024)
Pauline Thränhardt, Admirim Veselaj, Christoph Friedli, Franca Wagner, Stefanie Marti, Lara Diem, Helly N Hammer, Piotr Radojewski, Roland Wiest, Andrew Chan, Robert Hoepner, Salmen Anke
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events. Therapeutic advances in neurological disorders 17 (2024)
Yingying Zhang, Jiechuan Ren, Tianhua Yang, Weixi Xiong, Linyuan Qin, Dongmei An, Fayun Hu, Dong Zhou
Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia. Therapeutic advances in neurological disorders 17 (2024)
Jiamin Kang, Wenjun Wu, Xiangchuang Kong, Yu Su, Dingxi Liu, Chungao Li, Nan Gao, Youzhi Wang, Chuansheng Zheng, Yuxiong Weng, Lixia Wang
Improved visualization of median, ulnar nerves, and small branches in the wrist and palm using contrast-enhanced magnetic resonance neurography. Therapeutic advances in neurological disorders 17 (2024)
Yue Yu, Mingkang Zhong, Chao Quan, Chunlai Ma
Treatment access and satisfaction on disease-modifying therapies of neuromyelitis optica spectrum disorder patients in China: a cross-sectional survey. Therapeutic advances in neurological disorders 17 (2024)
Nicholas Riley, Susan Lavinia Greco, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van Der Walt, Erin O Y Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A Samjoo
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons. Therapeutic advances in neurological disorders 17 (2024)
Virgilio G H Evidente, Daryl DeKarske, Bruce Coate, Victor Abler
The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study. Therapeutic advances in neurological disorders 17 (2024)
Meagen Salinas, Umar Yazdani, Austin Oblack, Bradley McDaniels, Nida Ahmed, Bilal Haque, Nader Pouratian, Shilpa Chitnis
Know DBS: patient perceptions and knowledge of deep brain stimulation in Parkinson's disease. Therapeutic advances in neurological disorders 17 (2024)
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis. Therapeutic advances in neurological disorders 17 (2024)
Michail Papantoniou, Grigorios Panagopoulos
Concurrent acute sensorimotor axonal neuropathy and disseminated encephalitis associated with Chlamydia pneumoniae in an adult patient with anti-MOG and anti-sulfatide antibodies: a case report. Therapeutic advances in neurological disorders 17 (2024)
Abdul Wahid, Wajiha Fatima Khan, Yusra Khan
Promising advances in Alzheimer's treatment: donanemab's impact on disease progression and amyloid clearance. Therapeutic advances in neurological disorders 17 (2024)
Yuan Wang, Xiao Huan, Xinfang Zhu, Jie Song, Chong Yan, Lei Yang, Caihua Xi, Yafang Xu, Jianying Xi, Chongbo Zhao, Rong Xia, Su-Shan Luo
Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study. Therapeutic advances in neurological disorders 17 (2024)
Abdul Wahid, Wajiha Fatima Khan, Yusra Khan
Promising advances in Alzheimer's treatment: donanemab's impact on disease progression and amyloid clearance. Therapeutic advances in neurological disorders 17 (2024)
Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. Therapeutic advances in neurological disorders 17 (2024)
Jun-Seob Kim, Hyelim Park, Jung-Hwan Lee, Jongbeom Shin, Boram Cha, Kye Sook Kwon, Yong Woon Shin, Yerim Kim, YeoJin Kim, Jong Seok Bae, Ju-Hun Lee, Seok-Jin Choi, Tae Jung Kim, Sang-Bae Ko, Soo-Hyun Park
Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer's dementia following fecal microbiota transplantation: a preliminary study. Therapeutic advances in neurological disorders 17 (2024)
Yingying Zhang, Jiechuan Ren, Tianhua Yang, Weixi Xiong, Linyuan Qin, Dongmei An, Fayun Hu, Dong Zhou
Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia. Therapeutic advances in neurological disorders 17 (2024)
Valentin Loser, Thomas Baumgartner, Hélène Legardeur, Alice Panchaud, Marie Théaudin
Patisiran exposure in early pregnancy: a case report. Therapeutic advances in neurological disorders 17 (2024)
Lina Palaiodimou, Aristeidis H Katsanos, Guillaume Turc, Michele Romoli, Aikaterini Theodorou, Robin Lemmens, Simona Sacco, Georgios Velonakis, Charalambos Vlachopoulos, Georgios K Tsivgoulis
Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis. Therapeutic advances in neurological disorders 17 (2024)
Valentin Loser, Thomas Baumgartner, Hélène Legardeur, Alice Panchaud, Marie Théaudin
Patisiran exposure in early pregnancy: a case report. Therapeutic advances in neurological disorders 17 (2024)
Steffeni Papukchieva, Ann-Sophie Stratil, Maria Kahn, Nils-Henning Neß, Maike Hollnagel-Schmitz, Vivien Gerencser, Julia Rustemeier, Markus Eberl, Benjamin Friedrich, Tjalf Ziemssen
Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany. Therapeutic advances in neurological disorders 17 (2024)
Pauline Thränhardt, Admirim Veselaj, Christoph Friedli, Franca Wagner, Stefanie Marti, Lara Diem, Helly N Hammer, Piotr Radojewski, Roland Wiest, Andrew Chan, Robert Hoepner, Salmen Anke
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events. Therapeutic advances in neurological disorders 17 (2024)
Steffeni Papukchieva, Ann-Sophie Stratil, Maria Kahn, Nils-Henning Neß, Maike Hollnagel-Schmitz, Vivien Gerencser, Julia Rustemeier, Markus Eberl, Benjamin Friedrich, Tjalf Ziemssen
Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany. Therapeutic advances in neurological disorders 17 (2024)
Yue Yu, Mingkang Zhong, Chao Quan, Chunlai Ma
Treatment access and satisfaction on disease-modifying therapies of neuromyelitis optica spectrum disorder patients in China: a cross-sectional survey. Therapeutic advances in neurological disorders 17 (2024)
Suhui Kuang, Shaohui Zhang, Zhiqiang Cui, Ming Ge, Liu Yuan, Jiaqi Wang, Zhirong Wei, Jinshan Xu, Feng Zhai, Shuli Liang
Clinical characteristics and surgical outcomes of low-grade epilepsy-associated brain tumors. Therapeutic advances in neurological disorders 17 (2024)
Jiamin Kang, Wenjun Wu, Xiangchuang Kong, Yu Su, Dingxi Liu, Chungao Li, Nan Gao, Youzhi Wang, Chuansheng Zheng, Yuxiong Weng, Lixia Wang
Improved visualization of median, ulnar nerves, and small branches in the wrist and palm using contrast-enhanced magnetic resonance neurography. Therapeutic advances in neurological disorders 17 (2024)
Virgilio G H Evidente, Daryl DeKarske, Bruce Coate, Victor Abler
The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study. Therapeutic advances in neurological disorders 17 (2024)
Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Kathryn C Fitzgerald, Rodden M Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Salter Amber
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic advances in neurological disorders 17 (2024)
Meagen Salinas, Umar Yazdani, Austin Oblack, Bradley McDaniels, Nida Ahmed, Bilal Haque, Nader Pouratian, Shilpa Chitnis
Know DBS: patient perceptions and knowledge of deep brain stimulation in Parkinson's disease. Therapeutic advances in neurological disorders 17 (2024)
Michail Papantoniou, Grigorios Panagopoulos
Concurrent acute sensorimotor axonal neuropathy and disseminated encephalitis associated with Chlamydia pneumoniae in an adult patient with anti-MOG and anti-sulfatide antibodies: a case report. Therapeutic advances in neurological disorders 17 (2024)
Tobias Brummer, Johannes Lotz, Christian Dresel, Frank Birklein
Anti-NMDA-receptor encephalitis and concurrent neuroborreliosis misdiagnosed for post-COVID-19-syndrome: a case report. Therapeutic advances in neurological disorders 17 (2024)
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van Der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman, null null
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic advances in neurological disorders 17 (2024)
Simon Faissner, Marielena Bongert, Paulina Trendelenburg, Sandra Thiel, Takashi Yamamura, Kerstin Hellwig, Ralf Gold
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis. Therapeutic advances in neurological disorders 17 (2024)
Niklas Frahm, David Ellenberger, Alexander Stahmann, Firas Fneish, Daniel Lüftenegger, Hans C Salmen, Ksenija Schirduan, Tom P A Schaak, Peter Flachenecker, Christoph Kleinschnitz, Friedemann Paul, Dagmar Krefting, Uwe K Zettl, Melanie Peters, Clemens Warnke
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry. Therapeutic advances in neurological disorders 17 (2024)
Olaf Hoffmann, Ralf Gold, Sven G Meuth, Ralf A Linker, Thomas Skripuletz, Heinz Wiendl, Mike P Wattjes
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making? Therapeutic advances in neurological disorders 17 (2024)
Olaf Hoffmann, Ralf Gold, Sven G Meuth, Ralf A Linker, Thomas Skripuletz, Heinz Wiendl, Mike P Wattjes
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making? Therapeutic advances in neurological disorders 17 (2024)
Jens Kuhle, David Leppert, Giancarlo Comi, Nicola de Stefano, Ludwig Kappos, Mark S Freedman, Andrea Seitzinger, Sanjeev Roy
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic advances in neurological disorders 17 (2024)
Jens Kuhle, David Leppert, Giancarlo Comi, Nicola de Stefano, Ludwig Kappos, Mark S Freedman, Andrea Seitzinger, Sanjeev Roy
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic advances in neurological disorders 17 (2024)
Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. Therapeutic advances in neurological disorders 17 (2024)
Fang Fang, Xiao-Xi Lan, Rong-Hua Hu, Wu-Han Hui, Hong Zhao, Yi-Xian Guo, Bing-Xin Ji, Hong-Jun Liu, Li Su, Wan-Ling Sun
Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients. Therapeutic advances in neurological disorders 17 (2024)
Jun-Seob Kim, Hyelim Park, Jung-Hwan Lee, Jongbeom Shin, Boram Cha, Kye Sook Kwon, Yong Woon Shin, Yerim Kim, YeoJin Kim, Jong Seok Bae, Ju-Hun Lee, Seok-Jin Choi, Tae Jung Kim, Sang-Bae Ko, Soo-Hyun Park
Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer's dementia following fecal microbiota transplantation: a preliminary study. Therapeutic advances in neurological disorders 17 (2024)
Lina Palaiodimou, Aristeidis H Katsanos, Guillaume Turc, Michele Romoli, Aikaterini Theodorou, Robin Lemmens, Simona Sacco, Georgios Velonakis, Charalambos Vlachopoulos, Georgios K Tsivgoulis
Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis. Therapeutic advances in neurological disorders 17 (2024)